Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IGF1R | P08069 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | P2RX7 | Q99572 | 1/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13228907 | 0.96 | ALDH1A1 (0.34) | IGF1RALDH1A1POLBKMT2AP2RX7 | |
| SCHEMBL2401165 | 0.89 | P2RX7 (0.33) | ALDH1A1KMT2AP2RX7HSD17B10 | |
| SCHEMBL8719717 | 0.86 | IGF1R (0.31) | IGF1R | |
| SCHEMBL4107546 | 0.86 | P2RX7 (0.34) | IGF1RALDH1A1POLBKMT2AP2RX7 | |
| SCHEMBL22674288 | 0.85 | P2RX7 (0.30) | P2RX7 | |
| SCHEMBL14864027 | 0.81 | P2RX7 (0.36) | ALDH1A1POLBKMT2AP2RX7HSD17B10 | |
| SCHEMBL4279732 | 0.80 | — | — | |
| SCHEMBL7689059 | 0.79 | KMT2A (0.36) | IGF1RALDH1A1POLBKMT2AP2RX7 | |
| SCHEMBL29954782 | 0.78 | ALDH1A1 (0.37) | IGF1RALDH1A1POLBKMT2AHSD17B10 | |
| SCHEMBL8719716 | 0.77 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-3530529-B2 | — | — | 2004-05-24 | — | — | JP | claimed |
| US-5569759-A | MAGNETIC RESONANCE IMAGING; TUMOR THERAPY | BOARD OF REGENTS, UNIVERSITY OF TEXAS SYSTEM (US) | 1996-10-29 | — | — | US | claimed |
| EP-0623134-A1 | METAL COMPLEXES OF WATER SOLUBLE TEXAPHYRINS | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 1994-11-09 | — | — | EP | claimed |
| WO-1993014093-A1 | METAL COMPLEXES OF WATER SOLUBLE TEXAPHYRINS | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 1993-07-22 | — | — | WO | claimed |
| EP-3283493-B1 | TEXAPHYRIN-PHOSPHOLIPID CONJUGATES AND METHODS OF PREPARING SAME | UNIV HEALTH NETWORK UHN (CA) | 2020-11-18 | — | — | EP | disclosed |
| US-10729792-B2 | Texaphyrin-phospholipid conjugates and methods of preparing same | UNIVERSITY HEALTH NETWORK (CA) | 2020-08-04 | — | — | US | disclosed |
| US-20180104364-A1 | TEXAPHYRIN-PHOSPHOLIPID CONJUGATES AND METHODS OF PREPARING SAME | UNIVERSITY HEALTH NETWORK (CA) | 2018-04-19 | — | — | US | disclosed |
| US-20180104364-A1 | TEXAPHYRIN-PHOSPHOLIPID CONJUGATES AND METHODS OF PREPARING SAME | UNIVERSITY HEALTH NETWORK (CA) | 2018-04-19 | — | — | US | disclosed |
| WO-2016165006-A1 | TEXAPHYRIN-PHOSPHOLIPID CONJUGATES AND METHODS OF PREPARING SAME | UNIVERSITY HEALTH NETWORK (CA) | 2016-10-20 | — | — | WO | disclosed |
| EP-0623134-B1 | METAL COMPLEXES OF WATER SOLUBLE TEXAPHYRINS | UNIV TEXAS (US) | 2002-11-06 | — | — | EP | disclosed |
| US-5994535-A | Water soluble texaphyrin metal complex preparation | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 1999-11-30 | — | — | US | disclosed |
| EP-0462206-B1 | EXPANDED PORPHYRINS: LARGE PORPHYRIN-LIKE TRIPYRROLEDIMETHINE-DERIVED MACROCYCLES | UNIV TEXAS (US) | 1998-07-29 | — | — | EP | disclosed |
| US-5272142-A | Expanded porphyrins: large porphyrin-like tripyrroledimethine-derived macrocycles and methods for treating tumors | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 1993-12-21 | — | — | US | disclosed |
| US-5256399-A | Metallotexaphyrin complexes as photosensitizers for generation of singlet oxygen for destruction of human immunodeficiency virus | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 1993-10-26 | — | — | US | disclosed |
| US-5252720-A | Medical uses | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 1993-10-12 | — | — | US | disclosed |
| WO-1993014093-A1 | METAL COMPLEXES OF WATER SOLUBLE TEXAPHYRINS | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 1993-07-22 | — | — | WO | disclosed |
| US-5162509-A | Process for preparing expanded porphyrins: large porphyrin-like tripyrroledimethine-derived macrocycles | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 1992-11-10 | — | — | US | disclosed |
| EP-0462206-A1 | EXPANDED PORPHYRINS: LARGE PORPHYRIN-LIKE TRIPYRROLEDIMETHINE-DERIVED MACROCYCLES | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 1991-12-27 | — | — | EP | disclosed |
| WO-1990010633-A1 | EXPANDED PORPHYRINS: LARGE PORPHYRIN-LIKE TRIPYRROLEDIMETHINE-DERIVED MACROCYCLES | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 1990-09-20 | — | — | WO | disclosed |
| US-4935498-A | Expanded porphyrins: large porphyrin-like tripyrroledimethine-derived macrocycles | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 1990-06-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180104364-A1 | TEXAPHYRIN-PHOSPHOLIPID CONJUGATES AND METHODS OF PREPARING SAME | PLTP, PHOSPHO1, TEX13A | IGF1R 4769/4885ALDH1A1 4042/4885POLB 4354/4885 |
| US-10729792-B2 | Texaphyrin-phospholipid conjugates and methods of preparing same | PLTP, PHOSPHO1, TEX13A | IGF1R 4769/4885ALDH1A1 4042/4885POLB 4354/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.